U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07591428) titled 'Reset Challenge: Reducing High-risk Drinking for Cancer Prevention' on April 28. Brief Summ... Read More
U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590440) titled 'Indian Lung Screening Trial' on April 30. Brief Summary: The GLOBOCAN 2022 report for India... Read More
U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07591233) titled 'Pre-incisional Infiltration With Ropivacaine Plus Triamcinolone for Relieving Postoperative ... Read More
U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590388) titled 'Validation of the PRST Score Against Bispectral Index' on May 11. Brief Summary: The goal o... Read More
Singapore, May 16 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More
Singapore, May 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More
Singapore, May 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, May 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, May 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More
Singapore, May 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More